Company Filing History:
Years Active: 2023
Title: Innovations by Ching Sieu Tay in Gastroretentive Dosage Forms
Introduction
Ching Sieu Tay is an accomplished inventor based in Nottingham, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. Her work focuses on enhancing the delivery and efficacy of active ingredients in medication.
Latest Patents
Ching Sieu Tay holds a patent for a gastroretentive, sustained-release dosage form that includes 5-hydroxytryptophan (5-HTP) as an active ingredient. This patent describes a unique formulation that combines 5-HTP with low-dose carbidopa. The dosage form can be provided as a bilayer tablet, which consists of a swelling layer and a modified release layer. The innovative design allows for the parallel release of both 5-HTP and carbidopa, with approximately 80% of both ingredients being released within a timeframe of about 5 to 12 hours. This advancement has the potential to improve patient outcomes by ensuring a more consistent therapeutic effect.
Career Highlights
Ching Sieu Tay has dedicated her career to research and development in the pharmaceutical industry. Her innovative approach to dosage forms has garnered attention and respect within the scientific community. She continues to work on enhancing drug delivery systems to meet the evolving needs of patients.
Collaborations
Ching collaborates with Jacob Pade Ramsoe Jacobsen, contributing to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Ching Sieu Tay's work in developing gastroretentive dosage forms represents a significant step forward in pharmaceutical technology. Her contributions are poised to make a lasting impact on medication delivery and patient care.